fluorodeoxyglucose f18 has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimi, A; Iwasaki, S; Kamihara, Y; Kanisawa, Y; Minami, S | 1 |
| Boeckx, N; Deroose, CM; Dierickx, D; Gheysens, O; Goffin, KE; Morscio, J; Sagaert, X; Thielemans, S; Tousseyn, T; Verhoef, G; Wlodarska, I | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Myeloproliferative Disorders
| Article | Year |
|---|---|
Focal 18F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm.
Topics: Bone and Bones; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Janus Kinase 2; Magnetic Resonance Imaging; Middle Aged; Mutation; Myeloproliferative Disorders; Positron-Emission Tomography; Spine; Tomography, X-Ray Computed | 2014 |
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Bone Marrow Cells; Child; Female; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Male; Middle Aged; Myeloproliferative Disorders; Neoplasm Staging; Organ Transplantation; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2016 |